MedPath

Respiratory Muscle Function in Untreated X-Linked Myotubular Myopathy (XLMTM)

Completed
Conditions
X-linked Myotubular Myopathy
Interventions
Other: History and physical
Other: Tidal breathing
Other: Maximal respiratory pressures
Other: Peak cough flow
Other: Pediatric Evaluation of Disability Inventory
Other: PedsQL Multidimensional Fatigue Scale
Other: Review of ventilation requirements
Registration Number
NCT02453152
Lead Sponsor
University of Florida
Brief Summary

This study is a longitudinal study evaluating the severity and progression of respiratory muscle function in patients with X-Linked Myotubular Myopathy (XLMTM) aged 0-14.

Detailed Description

Subjects aged 0-7 will be evaluated every six months for a total of three evaluations (Baseline, Six-Month Visit, Twelve-Month Visit). Subjects aged 8-14 will be evaluated every twelve months for a total of two evaluations (Baseline, Twelve-Month Visit). Evaluations include medical history, physical exam, respiratory muscle tests, a qualitative interview related to the child's function and use of respiratory aids, and quality of life assessments.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
28
Inclusion Criteria
  • Patients who have centronuclear myopathy resulting from an MTM1 genetic mutation.
  • Patients who are between 0 and 14 years of age.
Read More
Exclusion Criteria
  • Patients without a confirmed genetic mutation.
  • Patients unable to travel to the site for the study.
  • Patients participating in an interventional treatment study for XLMTM at the time of enrollment.
  • Patients who are unable to complete study procedures.
  • Patients who have a condition that, in the opinion of the investigator, would make participation in this study unsafe.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Males with X-linked myotubular myopathyPeak cough flowHistory and physical, Tidal breathing, Maximal respiratory pressures, Peak cough flow, Pediatric Evaluation of Disability Inventory, PedsQL Multidimensional Fatigue Scale, Review of ventilation requirements
Males with X-linked myotubular myopathyPedsQL Multidimensional Fatigue ScaleHistory and physical, Tidal breathing, Maximal respiratory pressures, Peak cough flow, Pediatric Evaluation of Disability Inventory, PedsQL Multidimensional Fatigue Scale, Review of ventilation requirements
Males with X-linked myotubular myopathyPediatric Evaluation of Disability InventoryHistory and physical, Tidal breathing, Maximal respiratory pressures, Peak cough flow, Pediatric Evaluation of Disability Inventory, PedsQL Multidimensional Fatigue Scale, Review of ventilation requirements
Males with X-linked myotubular myopathyReview of ventilation requirementsHistory and physical, Tidal breathing, Maximal respiratory pressures, Peak cough flow, Pediatric Evaluation of Disability Inventory, PedsQL Multidimensional Fatigue Scale, Review of ventilation requirements
Males with X-linked myotubular myopathyHistory and physicalHistory and physical, Tidal breathing, Maximal respiratory pressures, Peak cough flow, Pediatric Evaluation of Disability Inventory, PedsQL Multidimensional Fatigue Scale, Review of ventilation requirements
Males with X-linked myotubular myopathyTidal breathingHistory and physical, Tidal breathing, Maximal respiratory pressures, Peak cough flow, Pediatric Evaluation of Disability Inventory, PedsQL Multidimensional Fatigue Scale, Review of ventilation requirements
Males with X-linked myotubular myopathyMaximal respiratory pressuresHistory and physical, Tidal breathing, Maximal respiratory pressures, Peak cough flow, Pediatric Evaluation of Disability Inventory, PedsQL Multidimensional Fatigue Scale, Review of ventilation requirements
Primary Outcome Measures
NameTimeMethod
Change in baseline visit off-ventilator tolerance at 6 month visit and 12 month visit.Change in baseline visit, at 6 month visit and 12 month visit
Secondary Outcome Measures
NameTimeMethod
Change in baseline tidal breathing at 6 month visit and 12 month visit.Change in baseline visit, at 6 month visit and 12 month visit

Subject's resting breathing pattern will be assessed.

Change in baseline peak cough flow at 6 month visit and 12 month visit.Change in baseline visit, at 6 month visit and 12 month visit

Subjects will be assessed on the ability to generate a cough and the strength of that cough.

Change in baseline visit maximal respiratory pressures at 6 month visit, and 12 month visit.Change in baseline visit, at 6 month visit and 12 month visit

Subject's maximal inspiratory and expiratory pressures.

Trial Locations

Locations (1)

University of Florida

🇺🇸

Gainesville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath